M Goldstein, B Anagnoste, A F Battista, S Nakatani, M Ogawa. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » 5-Hydroxytryptophan/pharmacologyAmines/metabolismAmino Acids/metabolismAnimalsAntiparkinson Agents/therapeutic useApomorphine/therapeutic useBasal Ganglia/metabolismBiogenic Amines/metabolismBrain/metabolismCarboxy-Lyases/metabolismCatechol O-Methyltransferase InhibitorsDihydroxyphenylalanine/pharmacologyDisease Models, AnimalDopamine/pharmacologyDopamine beta-Hydroxylase/bloodDopamine beta-Hydroxylase/metabolismHaplorhiniHumansMonoamine Oxidase Inhibitors/pharmacologyParkinson Disease/drug therapyParkinson Disease/enzymologyParkinson Disease/metabolismRatsTyrosine 3-Monooxygenase/metabolismVisual Cortex/enzymology
Substances： See more » AminesAmino AcidsAntiparkinson AgentsBiogenic AminesCatechol O-Methyltransferase InhibitorsMonoamine Oxidase InhibitorsDihydroxyphenylalanine5-HydroxytryptophanTyrosine 3-MonooxygenaseDopamine beta-HydroxylaseCarboxy-LyasesApomorphineDopamine
Year: 1972 PMID： 4403657
Source DB: PubMed Journal: Res Publ Assoc Res Nerv Ment Dis ISSN： 0091-7443